Effects of erlotinib on lung injury induced by intratracheal administration of bleomycin (BLM) in rats

Journal of Toxicological Sciences

Volumn 35, Issue 4, 2010, Pages 503-514

  Adachi, Kenji ^a   Mizoguchi, Keiji ^a   Kawarada, Shinya ^a   Miyoshi, Akio ^a   Suzuki, Masami ^a   Chiba, Shuichi ^a   Deki, Toshiaki ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Bleomycin; Epidermal growth factor receptor tyrosine kinase inhibitor; Erlotinib; Lung fibrosis; Rat

Indexed keywords

BLEOMYCIN; ERLOTINIB; HYDROXYPROLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DISEASE SEVERITY; HISTOPATHOLOGY; LUNG ALVEOLUS; LUNG FIBROSIS; LUNG INJURY; LUNG LESION; LUNG WEIGHT; MALE; NONHUMAN; RAT; SKIN DEFECT; WEIGHT GAIN;

CANIS FAMILIARIS; RATTUS;

EID: 77956827668     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.35.503     Document Type: Article

References (28)

1. Adachi, K., Suzuki, M., Sugimoto, T., Uetsuka, K., Nakayama, H. and Doi, K. (2001): Effects of granulocyte colony-stimulating factor on the development of inflammation in bleomycin-induced lung injury. J. Toxicol. Pathol., 14, 289-297.
2. Adachi, K., Suzuki, M., Sugimoto, T., Yorozu, K., Takai, H., Uetsuka, K., Nakayama, H. and Doi, K. (2003): Effects of granulocyte colony-stimulating factor (G-CSF) on bleomycin-induced lung injury of varying severity. Toxicol. Pathol., 31, 665-673.
3. Ashcroft, T., Simpson, J.M. and Timbrell, V. (1988): Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol., 41, 467-470.
4. Betsuyaku, T., Fukuda, Y., Parks, W.C., Shipley, J.M. and Senior, R.M. (2000): Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am. J. Pathol., 157, 525-535.
5. Betsuyaku, T., Kadomatsu, K., Griffin, G.L., Muramatsu, T. and Senior, R.M. (2003): Increased basigin in bleomycin-induced lung injury. Am. J. Respir. Cell Mol. Biol., 28, 600-606.
6. Bierman, A., Yerrapureddy, A., Reddy, N.M., Hassoun, P.M. and Reddy, S.P. (2008): Epidermal growth factor receptor (EGFR) regulates mechanical ventilation-induced lung injury in mice. Transl. Res., 152, 265-272.
7. Chandler, D.B., Hyde, D.M. and Giri, S.N. (1983): Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am. J. Pathol., 112, 170-177.
8. Fukuda, Y., Ferrans, V.J., Schoenberger, C.I., Rennard, S.I. and Crystal, R.G. (1985): Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis. Am. J. Pathol., 118, 452-475.
9. Fukuda, Y., Takemura, T. and Ferrans, V.J. (1989): Evolution of metaplastic squamous cells of alveolar walls in pulmonary fibrosis produced by paraquat. An ultrastructural and immunohistochemical study. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 58, 27-43.
10. Gibson, S., Tu, S., Oyer, R., Anderson, S.M. and Johnson, G.L. (1999): Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation. J. Biol. Chem., 274, 17612-17618.
11. Hay, J., Shahzeidi, S. and Laurent, G. (1991): Mechanisms of bleomycin-induced lung damage. Arch. Toxicol., 65, 81-94.
12. Ishii, Y., Fujimoto, S., and Fukuda, T. (2006): Gefitinib prevents bleomycin-induced lung fibrosis in mice. Am. J. Respir. Crit. Care Med., 174, 550-556.
13. Kataoka, K., Taniguchi, H., Hasegawa, Y., Kondoh, Y., Kimura, T., Nishiyama, O., Imaizumi, K., Kawabe, T., Kume, H. and Shimokata, K. (2006): Interstitial lung disease associated with gefitinib. Respir. Med., 100, 698-704.
14. Kawamoto, M. and Fukuda, Y. (1990): Cell proliferation during the process of bleomycin-induced pulmonary fibrosis in rats. Acta Pathol. Jpn., 40, 227-238.
15. Lazenby, A.J., Crouch, E.C., McDonald, J.A. and Kuhn, C.3rd. (1990): Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am. Rev. Respir. Dis., 142, 206-214.
16. Madtes, D.K., Busby, H.K., Strandjord, T.P. and Clark, J.G. (1994): Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am. J. Respir. Cell Mol. Biol., 11, 540-551.
17. Mautz, W.J., Kleinman, M.T., Phalen, R.F. and Crocker, T.T. (1988): Effects of exercise exposure on toxic interactions between inhaled oxidant and aldehyde air pollutants. J. Toxicol. Environ. Health, 25, 165-177.
18. Moyer, J.D., Barbacci, E.G., Iwata, K.K., Arnold, L., Boman, B., Cunningham, A., DiOrio, C., Doty, J., Morin, M.J., Moyer, M.P., Neveu, M., Pollack, V.A., Pustilnik, L.R., Reynolds, M.M., Sloan, D., Theleman, A. and Miller, P. (1997): Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res., 57, 4838-4848.
19. Nakamura, Y., Sotozono, C. and Kinoshita, S. (2001): The epidermal growth factor receptor (EGFR): role in corneal wound healing and homeostasis. Exp. Eye Res., 72, 511-517.
20. Nettesheim, P. and Szakal, A.K. (1972): Morphogenesis of alveolar bronchiolization. Lab. Invest., 26, 210-219.
21. Okazaki, T., Nakao, A., Nakano, H., Takahashi, F., Takahashi, K., Shimozato, O., Takeda, K., Yagita, H. and Okumura, K. (2001): Impairment of bleomycin-induced lung fibrosis in CD28-deficient mice. J. Immunol., 167, 1977-1981.
22. Petty, W.J., Dragnev, K.H., Memoli, V.A., Ma, Y., Desai, N.B., Biddle, A., Davis, T.H., Nugent, W.C., Memoli, N., Hamilton, M., Iwata, K.K., Rigas, J.R. and Dmitrovsky, E. (2004): Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers. Clin. Cancer Res., 10, 7547-7554.
23. Ranson, M., Mansoor, W. and Jayson, G. (2002): ZD1839 (IRESSA): a selective EGFR-TK inhibitor. Expert Rev. Anticancer Ther., 2, 161-168.
24. Shen, A.S., Haslett, C., Feldsien, D.C., Henson, P.M. and Cherniack, R.M. (1988): The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. Am. Rev. Respir. Dis., 137, 564-571.
25. Suzuki, H., Aoshiba, K., Yokohori, N. and Nagai, A. (2003): Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis. Cancer Res., 63, 5054-5059.
26. Thrall, R.S., McCormick, J.R., Jack, R.M., McReynolds, R.A. and Ward, P.A. (1979): Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am. J. Pathol., 95, 117-130.
27. Usuki, J. and Fukuda, Y. (1995): Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats. Pathol. Int., 45, 552-564.
28. Yara, S., Kawakami, K., Kudeken, N., Tohyama, M., Teruya, K., Chinen, T., Awaya, A. and Saito, A. (2001): FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice. Clin. Exp. Immunol., 124, 77-85.